To explore the role of MDSCs in EOC, we assessed the frequencies of M-MDSCs (CD11b+CD33+CD14+) and PMN-MDSCs (CD11b+CD33+CD15+) in peripheral blood and tumor tissues from patients with benign and malignant ovarian tumors. This evidence concerns the gene CD14 and ovarian cancer.